Chelsea Therapeutics Announces Results From Northera(TM) (droxidopa) Study in Spinal Cord Injury at the 23rd International Symposium on the Autonomic Nervous System

[at noodls] – CHARLOTTE, N.C., Nov. 6, 2012 (GLOBE NEWSWIRE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced results from a study of Northeraâ„¢ (droxidopa) in hypotensive individuals with spinal … more

View todays social media effects on CHTP

View the latest stocks trending across Twitter. Click to view dashboard